Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 3—March 2008

Sylvatic Dengue Virus Type 2 Activity in Humans, Nigeria, 1966

Scott C. Weaver*1, Robert B. Tesh*, and Nikos Vasilakis*Comments to Author 
Author affiliations: *University of Texas Medical Branch, Galveston, Texas, USA; 1Current affiliation: University of Pittsburgh, Pittsburgh, Pennsylvania, USA.;

Main Article


History of dengue virus type 2 isolates collected from patients with febrile illness in Ibadan, Nigeria, 1964–1968*

Isolate† Patient age/sex Source Passage history‡ Date of collection GenBank accession no.
IBH319 3 mo/F Blood NA 1964 Aug 11
IBH10126 8 y/M Blood NA 1966 Jun 1
IBH11208§ 3.5 y/F Blood SM5, C6/36 –1 1966 Aug 17 EF105307
IBH11234§ 31 y/M Blood SM16, C6/36 –1 1966 Aug 18 EU003591
IBH11358 5 mo/F Blood NA 1966 Aug 24
IBH11444 6 y/F Blood NA 1966 Aug 31
IBH11449 1.5 y/F Blood NA 1966 Aug 31
IBH11664§ 1.5 y/M Blood SM30, C6/36 –1 1966 Sep 12 EF105388
IBH11935A 13 y/M Blood NA 1966 Sep 23
IBH12541 23 y/M Serum NA 1966 Oct 17
IBH13028A 24 y/M Serum NA 1966 Nov 17
IBH24075 1.5 y/F Blood NA 1968 Jan 12
IBH26489A 5 y/M Blood NA 1968 Apr 24
IBH26953 3 y/M Blood NA 1968 May 15

*Available dengue virus isolates were obtained from the University of Texas Medical Branch World Reference Center for Emerging Viruses and Arboviruses.
†A complete inventory of dengue viruses isolated in Ibadan during 1964–1969 is described in the 1969 annual report of the University of Ibadan, Arbovirus Research Project, p. 152–7.
‡NA, not available; SM, suckling mouse; C6/36, Aedes albopictus cell line. –1 indicates that the virus isolates were passaged once in C6/36 cultures in our laboratory to obtain high-titer stocks.
§Virus isolates used in this study.

Main Article

1Current affiliation: University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Page created: July 07, 2010
Page updated: July 07, 2010
Page reviewed: July 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.